04/01/2025
7:30 AM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/28/2025
3:39 PM | MAIA Biotechnology (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/28/2025
6:01 AM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/26/2025
4:03 PM | MAIA Biotechnology (Filer)
| Form 424B5 | |
03/26/2025
4:14 PM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2025
3:31 PM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2025
3:30 PM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2025
3:42 PM | Guerrero Ramiro (Reporting)
MAIA Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
4:28 PM | FGMK Business Holdings, LLC (Filed by)
MAIA Biotechnology (Subject)
| Form SCHEDULE 13G | |
02/27/2025
4:00 PM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/25/2025
3:11 PM | Guerrero Ramiro (Reporting)
MAIA Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for MAIA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MAIA Biotechnology and its competitors with MarketBeat's FREE daily newsletter. |
02/25/2025
6:30 AM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2025
6:00 AM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
4:27 PM | Gryaznov Sergei (Filed by)
MAIA Biotechnology (Subject)
| Form SCHEDULE 13G/A | |
02/06/2025
3:30 PM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/05/2025
6:30 AM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2024
12:05 PM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/13/2024
4:15 PM | Guerrero Ramiro (Reporting)
MAIA Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/13/2024
4:17 PM | MAIA Biotechnology (Issuer)
Smith Stan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
5:32 AM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
11:51 AM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
3:25 PM | MAIA Biotechnology (Issuer)
Vitoc Vlad (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
4:00 PM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2024
3:39 PM | Luput Cristian (Reporting)
MAIA Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
5:17 AM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2024
5:16 PM | MAIA Biotechnology (Subject)
Smith Stan (Filed by)
| Form SC 13D/A | |
10/25/2024
4:10 PM | MAIA Biotechnology (Subject)
Vitoc Vlad (Filed by)
| Form SC 13D | |
10/25/2024
4:12 PM | Louie Ngar Yee (Filed by)
MAIA Biotechnology (Subject)
| Form SC 13D | |
10/02/2024
3:52 PM | Guerrero Ramiro (Reporting)
MAIA Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
3:54 PM | MAIA Biotechnology (Issuer)
Smith Stan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
3:55 PM | CHAOUKI STEVEN M (Reporting)
MAIA Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
5:15 AM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/23/2024
4:05 PM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2024
1:57 PM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
3:05 PM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
4:21 PM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
4:05 PM | Gryaznov Sergei (Reporting)
MAIA Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/26/2024
4:33 PM | Louie Ngar Yee (Reporting)
MAIA Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/26/2024
4:30 PM | MAIA Biotechnology (Issuer)
Smith Stan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
3:05 PM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
3:56 PM | Guerrero Ramiro (Reporting)
MAIA Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Elon Tax Shock? (Ad) Elon Musk's DOGE agents have some very strange plans for the IRS...
Recently, it emerged that our tax authorities have bought a powerful new AI supercomputer, worth millions of dollars.
It's the most advanced technology offered by AI giant Nvidia.
And it's almost certainly going to be used to advance Elon Musk's real agenda with DOGE... the massive, rapid roll out of AI across the entire federal government. Move now and you could get in first - with huge upside potential. |
04/02/2024
3:58 PM | CHAOUKI STEVEN M (Reporting)
MAIA Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:59 PM | Louie Ngar Yee (Reporting)
MAIA Biotechnology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
4:01 PM | MAIA Biotechnology (Issuer)
Smith Stan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
3:10 PM | MAIA Biotechnology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
